Class Numbers Added and Canceled
Class Numbers Added - 2025 Summer Edition |
||
New Number |
Class Name |
Former Number(s) |
QV 176 |
Tocolytic agents |
WK 102 |
QV 200 |
Lipid regulating agents |
None |
QV 205 |
Hypoglycemic agents |
WK 825 |
W 20.55.D5 |
Diffusion of innovation |
None |
W 20.55.O6 |
Operations research |
None |
W 26.55.A5 |
Algorithms |
W 26.5 |
W 26.55.C5 |
Cloud computing |
None |
W 26.55.C58 |
Computer security |
W 26.55.C7 |
W 26.55.D13 |
Data science |
None |
W 26.55.D14 |
Data visualization |
None |
W 26.55.D17 |
Database management systems |
W 26.55.I4 |
W 26.55.I2 |
Image processing, Computer-assisted |
None |
W 26.55.I35 |
Information storage and retrieval |
W 26.55.I4 |
W 26.55.M2 |
Machine learning |
W 26.55.A7 |
W 26.55.M25 |
Mathematical computing |
None |
W 26.55.M4 |
Medical informatics applications |
W 26.5 |
W 26.55.S4 |
Signal processing, computer-assisted |
W 26.5 |
W 26.55.S9 |
Systems analysis |
None |
W 26.55.T4 |
Telecommunications |
None |
WA 548 |
Reproductive health services (Table-G) |
WQ 200 |
WA 548.1 |
[Reproductive health services] General coverage (Not Table-G) |
WQ 200.1 |
WB 355 |
Placebos. Placebo effect |
WB 330 |
WH 710 |
Lymphoid tissue |
WH 700 |
WK 90 |
[Endocrine system] General works |
WK 100 |
WK 105 |
Androgens. Androgen antagonists |
WK 755 |
WK 110 |
Estrogens. Estrogen antagonists |
WP 522 |
WK 112 |
Estrogen replacement therapy |
WP 522 |
WK 220 |
Thyroid diseases (General or not elsewhere classified) |
WK 200 |
WK 517 |
Growth hormone |
WK 515 |
WK 812 |
Diabetes mellitus, Type I |
WK 810 |
WK 835.5 |
[Diabetes complications] Specific complications, A-Z |
WK 835 |
WK 835.5.A5 |
Diabetic angiopathies |
WK 835 |
WK 835.5.C2 |
Diabetic cardiomyopathies |
None |
WK 835.5.C6 |
Diabetic coma |
WK 830 |
WK 835.5.D2 |
Diabesity |
None |
WK 835.5.F5 |
Diabetic foot |
WK 835 |
WK 835.5.K4 |
Diabetic ketoacidosis |
WK 830 |
WK 835.5.N3 |
Diabetic nephropathies |
WK 835 |
WK 835.5.N6 |
Diabetic neuropathies |
WK 835 |
WK 835.5.R3 |
Diabetic retinopathy |
WK 835 |
WK 925 |
Corpus luteum hormones |
WP 530 |
WK 930 |
Gonadal steroid hormones |
WK 900 |
WK 932 |
Female gonadal steroid hormones |
None |
WK 933 |
Male gonadal steroid hormones |
None |
WK 935 |
Estradiol congeners |
WP 522 |
WK 940 |
Progesterone congeners |
None |
WK 945 |
Testicular hormones. Testosterone congeners |
WJ 875 |
WO 226.5 |
[Anesthesia and analgesia] Informatics. Electronic data processing. Computers |
None |
WP 20.5 |
Reproductive medicine as a profession. Ethics. Peer review |
WQ 200 |
WP 50 |
Reproductive health. Reproductive history (Table-G) |
WQ 200 |
WP 50.1 |
[Reproductive health. Reproductive history] General coverage (Not Table-G) |
WQ 200.1 |
WP 620 |
Reproductive techniques (General or not elsewhere classified) |
WQ 208 |
WQ 180 |
Perinatal care |
WQ 210 |
WQ 201 |
Pregnancy in Adolescence (General) |
WQ 215-WQ 270 |
WQ 208.2 |
Artificial insemination |
WQ 208 |
WQ 208.4 |
Fertilization in vitro |
WQ 208 |
WQ 209.5 |
Fetal monitoring |
WQ 209 |
WQ 254 |
High-Risk pregnancy |
WQ 240 |
WQ 445 |
Induced abortion |
WQ 440 |
WQ 507 |
Postpartum depression |
WQ 500 |
WS 462.5.S55 |
[Adolescent psychology] Smoking. Tobacco use |
None |
Class Numbers Canceled - 2025 Summer Edition |
||
Canceled Number |
Class Name |
Now Classed in |
QU 87 |
Hypolipidemic agents |
QV 200 |
WJ 875 |
Testicular hormones and antagonists |
WK 945 |
WK 180 |
Renal hormones |
WJ 301 |
WK 201 |
[Thyroid gland] Anatomy. Histology. Embryology. Abnormalities |
WK 200 |
WK 267 |
[Thyroid diseases] Medical therapy |
WK 265 |
WK 400 |
Thymus gland |
WH 710 |
WK 501 |
[Pituitary gland] Anatomy. Histology. Embryology |
WK 500 |
WK 701 |
[Adrenal glands] Anatomy. Histology. Embryology. Abnormalities |
WK 700 |
WK 702 |
[Adrenal glands] Physiology. Biochemistry |
WK 700 |
WK 801 |
[Islets of Langerhans] Anatomy. Histology. Embryology |
WK 800 |
WK 802 |
[Islets of Langerhans] Physiology. Biochemistry |
WK 800 |
WK 825 |
Other hypoglycemic agents |
QV 205 |
WK 830 |
Diabetic ketoacidosis. Diabetic coma |
WK 835.5.C6; WK 835.5.K4 |
WK 840 |
Diabetes as a complication in other conditions |
WK 835 |
WK 870 |
Glycosurias |
QU 260.5.G6 |
WK 920 |
Placental hormones |
WQ 212 |
WP 520 |
Endocrine functions of the ovaries |
WP 320 |
WP 522 |
Estrogenic hormones and antagonists |
WK 110; WK 935 |
WP 530 |
Corpus luteum hormones and related compounds |
WK 925; WK 940 |
WQ 90 |
Reproductive health surveys (Table-G) |
WP 50 |
WQ 90.1 |
[Reproductive health surveys] General coverage (Not Table-G) |
WP 50.1 |